Laura Ciarloni

Laura Ciarloni is an experienced professional in the field of clinical research and development, with a background in biological sciences. Laura has held various roles in companies such as Novigenix SA, Diagnoplex SA, and Philip Morris International, where Laura has managed and contributed to the development of diagnostic tests for colorectal cancer. Their expertise includes leading biomarker discovery projects, managing clinical studies, and scientific publications. Their educational background includes a PhD in Biological Sciences and additional certifications in management in the biotech industry.